ReviewMolecular therapy. Methods & clinical development2023

Necessity of strengthening the current clinical regulatory for companion diagnostics: An institutional comparison of the FDA, EMA, and MFDS.

Su Lim Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.